baicalin has been researched along with Shock, Septic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gong, LK; Liu, LL; Qi, XM; Ren, J; Wang, H; Wu, XF; Xiao, Y; Xue, X; Zhang, YH | 1 |
| Iwahashi, N; Nose, M; Ogihara, Y; Oguri, K; Terawaki, K | 1 |
2 other study(ies) available for baicalin and Shock, Septic
| Article | Year |
|---|---|
Baicalin inhibits macrophage activation by lipopolysaccharide and protects mice from endotoxin shock.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Line; Disease Models, Animal; Flavonoids; Lipopolysaccharides; Macrophage Activation; Macrophages, Peritoneal; Male; Mice; Mice, Inbred BALB C; Shock, Septic | 2008 |
Comparative study of the high molecular mass fraction and low molecular mass fraction of Sho-saiko-to in a murine immunologically induced liver injury model.
Topics: Animals; BCG Vaccine; Chemical and Drug Induced Liver Injury; Chromatography, High Pressure Liquid; Drugs, Chinese Herbal; Flavonoids; Glycyrrhizic Acid; Lipopolysaccharides; Male; Mice; Mice, Inbred ICR; Molecular Weight; Nitric Oxide; Shock, Septic | 2002 |